1. Home
  2. HROW vs UPBD Comparison

HROW vs UPBD Comparison

Compare HROW & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • UPBD
  • Stock Information
  • Founded
  • HROW 1998
  • UPBD 1986
  • Country
  • HROW United States
  • UPBD United States
  • Employees
  • HROW N/A
  • UPBD N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • UPBD Diversified Commercial Services
  • Sector
  • HROW Health Care
  • UPBD Consumer Discretionary
  • Exchange
  • HROW Nasdaq
  • UPBD Nasdaq
  • Market Cap
  • HROW 1.4B
  • UPBD 1.6B
  • IPO Year
  • HROW N/A
  • UPBD 1995
  • Fundamental
  • Price
  • HROW $36.81
  • UPBD $21.38
  • Analyst Decision
  • HROW Strong Buy
  • UPBD Strong Buy
  • Analyst Count
  • HROW 7
  • UPBD 4
  • Target Price
  • HROW $68.50
  • UPBD $37.25
  • AVG Volume (30 Days)
  • HROW 804.0K
  • UPBD 610.5K
  • Earning Date
  • HROW 11-10-2025
  • UPBD 10-30-2025
  • Dividend Yield
  • HROW N/A
  • UPBD 6.75%
  • EPS Growth
  • HROW N/A
  • UPBD 78.87
  • EPS
  • HROW N/A
  • UPBD 1.79
  • Revenue
  • HROW $227,661,000.00
  • UPBD $4,481,986,000.00
  • Revenue This Year
  • HROW $43.92
  • UPBD $10.12
  • Revenue Next Year
  • HROW $41.22
  • UPBD $8.60
  • P/E Ratio
  • HROW N/A
  • UPBD $12.90
  • Revenue Growth
  • HROW 47.69
  • UPBD 7.49
  • 52 Week Low
  • HROW $20.85
  • UPBD $19.65
  • 52 Week High
  • HROW $54.19
  • UPBD $36.00
  • Technical
  • Relative Strength Index (RSI)
  • HROW 38.13
  • UPBD 39.42
  • Support Level
  • HROW $36.20
  • UPBD $22.34
  • Resistance Level
  • HROW $39.77
  • UPBD $23.89
  • Average True Range (ATR)
  • HROW 1.89
  • UPBD 0.74
  • MACD
  • HROW -0.40
  • UPBD 0.12
  • Stochastic Oscillator
  • HROW 9.98
  • UPBD 25.99

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: